Ignite Creation Date:
2024-05-06 @ 2:02 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04195217
Status:
UNKNOWN
Last Update Posted:
2021-12-17
First Post:
2019-11-08
Brief Title:
Application of Art Therapy in Oncology Evaluation of the Symptomatic of Patients Suffering From a Cancerous Disease
Sponsor:
Centre Hospitalier de Perigueux
Organization:
Centre Hospitalier de Perigueux
Study Overview
Official Title:
Application of Art Therapy in Oncology Evaluation of the Symptomatic of Patients Suffering From a Cancerous Disease
Status:
UNKNOWN
Status Verified Date:
2021-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ARONCO
Brief Summary:
The purpose of this study is to evaluate the impact of art-therapeutic management on a patient with cancer during chemotherapy treatment on the reduction of physical or psychological symptoms
Art therapy is a non-drug approach that can help some patients cope with the consequences of cancer beyond the care provided
The common psychosocial difficulties experienced by cancer patients are pain fatigue depression anxiety drowsiness In sum the well-being and quality of life of the patient throughout the illness
The main objective is to evaluate the impact of art therapy as a supportive care on improving the well-being felt after a session of cancer treatments chemotherapy immunotherapy during 6 sessions around 24 days between 2 sessions at patients with a cancer pathology using two questionnaires one on the evaluation of symptoms ESAS the other on the quality of life FACT-G
Art therapy is a non-drug approach that can help some patients cope with the consequences of cancer beyond the care provided
The common psychosocial difficulties experienced by cancer patients are pain fatigue depression anxiety drowsiness In sum the well-being and quality of life of the patient throughout the illness
The main objective is to evaluate the impact of art therapy as a supportive care on improving the well-being felt after a session of cancer treatments chemotherapy immunotherapy during 6 sessions around 24 days between 2 sessions at patients with a cancer pathology using two questionnaires one on the evaluation of symptoms ESAS the other on the quality of life FACT-G
Detailed Description:
Patients will be randomized into the following groups
Group 1 Art therapy as supportive care in 6 consecutive sessions of cancer treatments with or without additional supportive care
Group 2 6 consecutive sessions of cancer treatments with or without additional supportive care
Symptom assessment with the Edmonton Symptom Assessment System ESAS is done before and after each treatment session for each patient
The FACT-G questionnaire on the quality of life at the beginning and the end of the care for the two groups group benefiting from the art-therapy and group not benefiting from the art-therapy and a questionnaire on the contribution of art therapy at the end of care for the participants of the art-therapy group
Group 1 Art therapy as supportive care in 6 consecutive sessions of cancer treatments with or without additional supportive care
Group 2 6 consecutive sessions of cancer treatments with or without additional supportive care
Symptom assessment with the Edmonton Symptom Assessment System ESAS is done before and after each treatment session for each patient
The FACT-G questionnaire on the quality of life at the beginning and the end of the care for the two groups group benefiting from the art-therapy and group not benefiting from the art-therapy and a questionnaire on the contribution of art therapy at the end of care for the participants of the art-therapy group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None